icon2

Dillon Capital, LLC

Where Knowledge Creates Opportunity
And Experience Enhances Growth

Portfolio Companies

Hydrograph Clean Power

A Public company based in Vancouver. HydroGraph is one of the world’s purest producers of graphene, currently positioned to be a global leader in commercializing graphene at scale. HydroGraph’s patented technology uniquely positions the company for multiple high-growth markets in the production of graphene, and other strategic materials.
 

Properties of Pure Graphene

STRENGTH 200x stronger than steel composite 
FLEXIBILITY Can bend & stretch to 120% of the original size 
THERMAL CONDUCTIVITY 10x conductivity of copper  
IMPERMEABILITY Hydrogen atoms cannot penetrate its structure   
ELECTRICAL CONDUCTIVITY 1000x current capacity of copper
ELECTRONIC BEHAVIOUR Electrons can move at near-light speed through it  
OPTICAL PROPERTIES Highly transparent   
US-Medical-logo

A private company based in Takoma Park, Maryland  The company has in excess of 200 patents filed for and. or granted. The FDA recently approved USMI’s cutting-edge surgical device for cancer treatment, and awarded the company de novo status.

USMI: The Future of Surgery

USMI is dedicated to innovation in the fields of electrosurgery and plasma technology for the advancement of patient outcomes, the eradication of cancer and the improvement of human lives. Our Core Values of Innovation, Diversity, and Community are key to our pursuit of this mission and to our ongoing success.

INNOVATION

Leveraging the insights of our CEO and Co-Founder, in his capacity as both a transplant surgeon and inventor, we constantly look to the needs of our patients and doctors to understand the areas of greatest urgency for the development of new medical tools. This understanding drives the development of our pipeline of surgical devices as we seek to push the boundary of new technologies in the fields of electrosurgery, plasma surgery, and minimally invasive surgical and endoscopic procedures. For this reason, a large portion of our operation is dedicated to research and development of new patents and products. Through our sister company, Plasma Medicine Life Science, we are working to develop our ground-breaking Helios™ Cold Plasma product line for the eradication of cancer.

DIVERSITY

USMI is the first major US biomedical devices company to be majority owned and operated by women. We believe that our diverse cultural, academic and professional backgrounds, as well as our commitment to diversity of thought, are keys to our ability to successfully provide market-leading technologies and cutting-edge resources for both the public and the medical community.  

A private company based in Lincolnshire, IL. Synaptent’s primary division, Liftmode, develops cutting edge, premium nutraceutical products for the nutrition psychology sector; namely, remedies that address mood (anxiety and depression), cognitive (memory, focus, and concentration), and longevity, using natural enhancing compounds. Synaptent’s secondary division, NewMind, develops products that support research in biochemistry, longevity, and neuroscience.
 
Synaptent has over 45,000 active customers and had record revenues in 2022, up approximately 33% from 2021.